Skip to content
Riskpilot
← Back to search
Sign in
Get full access
IRISLEGENE AS
AS
Active
Org 914727200
Hamnevegen 48, 5200
Os
General medical practice activities
· NACE 8621
Est. 2014
8 employees
Watchlist
Share
Norway
/
Companies
/
General medical practice activities
/
IRISLEGENE AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
3M
5M
7M
4M
2021
4M
2022
5M
2023
5M
2024
6M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
4 233
4 437
4 847
5 343
5 785
Staff expenses
−2 483
−2 437
−2 789
−2 722
−2 946
EBITDA
89
71
11
12
32
Depreciation & amort.
−89
−71
−11
−11
−32
EBIT
0
0
0
1
0
Net financials
0
−0
−0
−1
−0
Profit before tax
0
0
−0
0
−0
Tax
2
3
−0
21
5
Net profit
−2
−3
−0
−20
−5
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
603
348
736
813
906
Equity
13
10
10
−10
−15
Long-term debt
0
0
0
0
0
Short-term debt
590
338
725
823
922
Total debt
590
338
725
823
922
Financial ratios
5-year trend
EBITDA margin
0.6%
This company
15.8%
Market median
-96% vs market
2021
2025
Equity ratio
-1.7%
This company
38.2%
Market median
-104% vs market
2021
2025
Return on equity
-501600.0%
This company
18.4%
Market median
-2726187% vs market
2021
2025
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
2021
2025
Asset turnover
6.38×
This company
1.12×
Market median
+470% vs market
2021
2025
Debt / equity
60.34×
This company
0.62×
Market median
-9632% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on IRISLEGENE AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network